TxBench-Antibody Launches 60-Task Benchmark Spanning Antibody Development

A team has released TxBench-Antibody Development, a verifiable benchmark of 60 evaluations covering seven stages of therapeutic antibody development, from molecule selection through first-in-human dosing, to test AI agents' drug development decisions.

2026-11-05 ~ 2026-11-05 · 2 related posts

• TxBench–Antibody Development: 60 verifiable evals across 7 drug-development stages — kenbwork · 2026-11-05

1 near-duplicate retellings: kenbwork